Fibular aplasia in a child exposed to sodium valproate in pregnancy

Clinical Dysmorphology

Volumn 18, Issue 1, 2009, Pages 37-39

  Cole, Rachel Louise ^a   Van Ross, Ernest R ^b,c   Clayton Smith, Jill ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

^c BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

APLASIA; ARTICLE; BONE RADIOGRAPHY; CASE REPORT; CHILD; CLINICAL FEATURE; EPILEPSY; FEMALE; FIBULAR APLASIA; HUMAN; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTICONVULSANTS; FEMALE; FIBULA; HUMANS; INFANT; MATERNAL EXPOSURE; PREGNANCY; VALPROIC ACID;

EID: 58149214133     PISSN: 09628827     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCD.0b013e3283155170     Document Type: Article

References (6)

1. Graham JM Jr, Sharony R, Garber A, Schreck R, Platt LD, Buehler BA (1991). Preaxial ray reduction defects valproate exposure during pregnancy. Teratology 43:441.
2. Lewin SO, Opitz JM (1986). Fibular a/hypoplasia: review and documentation of the fibular developmental field. Am J Med Genet Suppl 2:215-238.
3. Mast TJ, Cukierski MA, Nau H, Hendrickx AG (1986). Predicting the human teratogenic potential of the anti-convulsant, Valproic acid, from a non-human primate model. Toxicology 39:111-119.
4. Pandya NA, Jani BR (2000). Post-axial limb defects with maternal sodium valproate exposure. Clin Dysmorphol 9:143-144.
5. Sharony R, Garber A, Viskochil D, Schreck R, Platt LD, Ward R, et al. (1993). Preaxial ray reduction defects as part of embryofetopathy. Prenat Diagn 13:909-918.
6. Stanitski DF, Stanitski CL (2003). Fibular hemimelia: a new classification system. J Pediatr Orthop 23:30-34.